Medtronic MiniMed, Inc. is recalling 8,986 InPen smart insulin pens due to a manufacturing defect where the pens were incorrectly assembled. This issue can prevent the insulin cartridge from fitting into the holder or make it very difficult to remove the cartridge holder from the pen. If you cannot use the device and do not have a backup insulin delivery method available, you may experience high blood sugar (hyperglycemia).
The incorrect assembly of the insulin pen prevents proper use of the device, which can lead to delayed or missed insulin doses. While no injuries have been reported to date, this defect may cause temporary hyperglycemia, a condition that can be serious if not addressed promptly with backup insulin.
You have 2 options:
Recall #: Z-1650-2025
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.